Dataset from A Phase III, Double-blind, Placebo-controlled, Randomised Withdrawal, Multicentre, Extension, Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17 With Attention- Deficit/Hyperactivity Disorder (ADHD)
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00006852
下载链接
链接失效反馈官方服务：
资源简介：
The main aim of this study is to evaluate the long-term maintenance of efficacy of LDX after
administered to children and adolescents aged 6-17 with ADHD for at least 6 months
创建时间：
2024-11-26
